Study finds widely prescribed opioid painkiller tramadol shows limited effectiveness for chronic pain while increasing risk ...
TipRanks on MSN
Regeneron advances phase 3 antibody trial in birch pollen eye allergy: What investors should know
Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study OverviewRegeneron Pharmaceuticals has launched a new ...
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results We conducted a prospective ...
A new study finds that risk-based breast cancer screening could be as safe as annual mammograms, but an expert warns it may ...
ScienceAlert on MSN
Giant Study Reveals a Major Surprise About Medical Cannabis
Medicinal cannabis is increasingly used to treat a variety of conditions, but a comprehensive new review suggests that there ...
Doctors typically recommend that people with heart issues like A-Fib avoid caffeine out of fear that it will trigger symptoms. But a study by UC San Francisco and the University of Adelaide concluded ...
In a randomized clinical trial, researchers found risk-based breast cancer screening was as safe as annual screening for detecting ...
A new study led by researchers at Wake Forest University School of Medicine and Atrium Health Levine Cancer has found that a ...
Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the first patient has been randomized in the RASolute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback